Mangalam Drug Chem Share Price

₹ 29.18

+₹0.57 (1.99%)
1D
Last updated 02 Nov, 2026, 13:30 IST
NSE: MANGALAM
|
Pharmaceuticals

Mangalam Drug Chem Share Price Today

As of 2 Nov 2026, Mangalam Drug Chem share price is ₹29.18. The stock opened at ₹28.99, compared to its previous close of ₹28.61. During today's trading session, Mangalam Drug Chem share price moved in the range of ₹28.34 to ₹29.49, with an average price of ₹28.91 for the day. Looking at its last 52-week, the stock has touched a low of ₹22.80 and a high of ₹68.40. On the performance front, Mangalam Drug Chem share price has declined by 2.95% over the last six months and is down 56.63% on a year-on-year basis.

Share price over the last 1 day rose from 28.99 to 29.18, ranging between 28.40 and 29.49.
₹28.34
1.99% up today
₹29.49
1D LOW
1D HIGH

Mangalam Drug Chem Stock Insights

Latest Earning
Op Profit TrendUp by 49.13% QoQ
Latest Earning
Net Profit TrendUp by 43.07% QoQ
Latest Earning
Revenue TrendDown by 15.06% QoQ
Stock Performance
OutperformingBeat Nifty by 10.99 % in last 3 month
Mangalam Drug Chem stock performance
Open₹28.99
High₹29.49
Low₹28.34
Prev. close₹28.61
Mangalam Drug Chem trading activity
Volume7,126
Average traded price₹28.79
Last traded time01:30:48 02 Nov
Last traded quantity68
Circuit
L
H
₹25.75
₹31.47
52-week
L
H
₹22.80
₹68.40
Mkt Cap Cr
45.78
P/E
-1.2
P/B
0.48
ROA
-12.14%
ROE
-43.08%
ROCE
-15.4%
Quick Ratio
0.27
EV/EBITDA
-18.19

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Mangalam Drugs has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Mangalam Drugs appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Mangalam Drugs earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Mangalam Drug Chem Company Background

ISIN
INE584F01014
Sector Market Cap
₹ 45.78 Cr

Mangalam Drugs and Organics Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs) and intermediates. Under the Company's Fight Malaria Program, it supplies anti-malaria APIs worldwide. Its products include API, intermediates and specialty chemicals. Its API products include acyclovir, amodiaquine, artemether, artesunate, atazanavir sulfate, bisoprolol fumarate, chloroquine phosphate, furosemide and dolutegravir sodium. The Company's intermediates products include 4,6-Dichloro-5-Methoxy Pyrimidine; 4,7- dichloroquinoline; ortho phenoxy methane sulfonanilide; tenofovir alafenamide base, and tenofovir disoproxil base. Its specialty chemical products include L (+)-menthol; 2,3-dihydrophthalazine-1,4-dione or phthalazine-1,4-dione, and 4-cynoethyl-2-methyl phenol. Its pipeline APIs (under development) include Ganaplacide (IH), Tafenoquine Succinate (IH) and Pretomanid (IH). Its pipeline APIs (developed for research and development) is Bictegravir Na (IH).

Mangalam Drug Chem Financial Highlights

  • Revenue: Mangalam Drug Chem reported revenue of ₹232.89 crore in FY26 vs ₹318.74 crore in FY25. It showed a decrease of 26.93% on a yearly basis.
  • Operating Profit: Mangalam Drug Chem reported an operating loss of ₹48.57 crore in FY26 vs ₹4.79 crore in FY25. It showed a decrease of 1,113.99% on a year-on-year basis.
  • Net Profit: Mangalam Drug Chem reported a net loss of ₹44.40 crore in FY26 vs ₹6.72 crore in FY25. It showed a decrease of 760.71% on a yearly basis.

Mangalam Drug Chem Quarterly Result Highlights

  • Mangalam Drug Chem reported revenue of ₹57.23 crore in Jun 2026, compared with ₹67.38 crore in Mar 2026, representing a decrease of 15.06% on a quarter-on-quarter (QoQ) basis.
  • Mangalam Drug Chem reported an operating loss of ₹6.75 crore in Jun 2026, compared with ₹13.27 crore in Mar 2026, representing an increase of 49.13% on a quarter-on-quarter (QoQ) basis.
  • Mangalam Drug Chem reported a loss of ₹7.64 crore in Jun 2026, compared with ₹13.42 crore in Mar 2026, reflecting an increase of 43.07% on a QoQ basis.
  • The earnings per share (EPS) of Mangalam Drug Chem stood at ₹28.05 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
35.65%
FII
0.11%
Other DII
0.00%
Retail and other
64.24%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.13%
Mar 20260.32%
Jun 20260.11%
Sep 20260.11%

Mangalam Drug Chem Investment Returns

1 day
-2.09%
1 week
-0.14%
1 month
-6.93%
1 year
-56.63%
3 years
-71.66%
5 years
-78.69%

Mangalam Drug Chem Share Price History

Mangalam Drug Chem share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹29.48 / ₹28.61
-2.09%
29 Oct 26
₹29.01 / ₹29.22
+0.38%
28 Oct 26
₹28.99 / ₹29.11
+1.01%
27 Oct 26
₹28.90 / ₹28.82
+2.20%
Show more

Mangalam Drug Chem Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024
Revenue₹232.13₹317.58₹368.59
Other Income₹0.76₹1.16₹0.10
Total Revenue₹232.90₹318.73₹368.69
Total Expenses₹281.47₹313.95₹379.77
Profit Before Tax-₹48.57₹4.79-₹11.07
Tax-₹4.17-₹1.93-₹2.00
Profit After Tax-₹44.40₹6.72-₹9.07
EPS - Basic-₹28.05₹4.25-₹5.73
EPS - Diluted-₹28.05₹4.25-₹5.73

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024
Profit before tax-₹48.57₹4.79₹3.97
Income before WC changes-₹15.85₹35.38₹17.92
Change in Assets₹43.11-₹21.30₹29.86
Change in Liabilities-₹22.79₹28.59-₹43.77
Change in WC₹20.32₹7.29-₹13.91
Cash flow from Operations₹4.18₹42.59₹3.91
Cash flow from Investing-₹11.72-₹19.47-₹11.83
Cash flow from Financing₹5.66-₹21.71₹5.23
Total Cash Flow-₹1.89₹1.41-₹2.69
Cash (Start of the year)₹2.59₹1.18₹3.87
Cash (End of the year)₹0.70₹2.59₹1.18

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024
Non-Current Assets₹159.26₹167.42₹157.70
Current Assets₹155.71₹199.00₹176.00
Total Assets₹314.97₹366.42₹333.70
Current Liabilities₹196.58₹191.60₹164.06
Net Current Asset-₹40.87₹7.40₹11.94
Non-Current Liabilities₹15.33₹25.84₹33.85
Equity Capital₹103.06₹148.98₹135.79
Total Equity & Liabilities₹314.97₹366.42₹333.70

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹232.13₹317.58₹368.59₹372.25
Other Income₹0.76₹1.15₹0.10₹0.44
Total Revenue₹232.90₹318.73₹368.69₹372.69
Total Expenses₹280.88₹313.74₹379.75₹370.47
Profit Before Tax-₹47.99₹4.99-₹11.06₹2.21
Tax-₹4.17-₹1.93-₹2.01₹0.94
Profit After Tax-₹43.81₹6.92-₹9.05₹1.27
EPS - Basic-₹27.68₹4.37-₹5.72₹0.80
EPS - Diluted-₹27.68₹4.37-₹5.72₹0.80

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹47.99₹4.99-₹11.06₹2.21
Income before WC changes-₹15.65₹35.36₹16.75₹26.34
Change in Assets₹43.12₹2.64₹4.02-₹19.29
Change in Liabilities-₹23.01₹4.84-₹8.42₹31.01
Change in WC₹20.10₹7.49-₹4.39₹11.72
Cash flow from Operations₹4.16₹42.76₹12.17₹38.08
Cash flow from Investing-₹11.72-₹19.47-₹17.90-₹22.17
Cash flow from Financing₹5.66-₹21.71₹5.70-₹16.82
Total Cash Flow-₹1.90₹1.57-₹0.04-₹0.91
Cash (Start of the year)₹2.57₹1.00₹1.04₹1.95
Cash (End of the year)₹0.67₹2.57₹1.00₹1.04

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹152.45₹160.23₹157.36₹154.72
Current Assets₹155.69₹199.01₹199.78₹203.26
Total Assets₹308.14₹359.24₹357.14₹357.98
Current Liabilities₹189.49₹184.74₹180.95₹163.71
Net Current Asset-₹33.80₹14.27₹18.83₹39.55
Non-Current Liabilities₹15.33₹25.84₹33.85₹42.32
Equity Capital₹103.32₹148.66₹142.35₹151.96
Total Equity & Liabilities₹308.14₹359.24₹357.14₹357.98
* All values are in INR Crore
Mangalam Drug Chem market depth
Bid quantityBid priceAsk priceAsk quantity
1028.7529.147
228.7229.15202
4828.7129.49653
5228.729.745
3028.5729.7450
Total bid quantity142
Total ask quantity957
Mangalam Drug Chem technical summary
Bearish indicators1
Neutral indicators3
Bullish indicators4
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
40.56
Neutral
ATR (14)
1.47
Neutral
STOCH(9,6)
12.91
Bullish
STOCH RSI (14)
18.48
Bullish
ADX(9)
12.7
Bullish
UO(9)
30.67
Neutral
ROC(12)
-10.73
Bearish
WillR(14)
-88.13
Bullish
Period
Simple value
Exponential vaue
5D
28.79
28.98
10D
29.42
29.44
20D
30.4
30.09
50D
30.96
30.33
100D
29.46
30.05
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Mangalam Drug Chem
Pharmaceuticals
Add Stock
Add Another

Mangalam Drug Chem Returns Calculator

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹291.40
+39.55 (+15.7%)
PRAJIND Share Price
₹270.68
+28.98 (+11.99%)
DIXON Share Price
₹12279.00
+1279 (+11.63%)
MSUMI Share Price
₹39.02
+3.88 (+11.04%)
See more

Top Losers

INDIGOPNTS Share Price
₹880.70
-116.6 (-11.69%)
CLEAN Share Price
₹666.80
-48.8 (-6.82%)
ZEEL Share Price
₹61.97
-4.43 (-6.67%)
POLICYBZR Share Price
₹934.70
-65.4 (-6.54%)
SYRMA Share Price
₹1527.10
-98.2 (-6.04%)
See more

Mangalam Drug Chem Share Price FAQs

Please be aware that Mangalam Drug Chem stock prices are subject to continuous fluctuations due to various factors.